/
Login
ATSAT & S Austria Technologie & Systemtechnik Aktiengesellschaft
🇦🇹 Avusturya Borsası
153.20
EUR
Analysis Scores
Damodaran ?
19/100
Dalio Risk ?
53/100
Piotroski ?
5/9
Neutral
Previous period ROA data missing (C1 delta-ROA); Önceki yıl borç/varlık verisi yok → kaldıraç azalması kontrol edilemedi (C5); Previous year data missing → margin comparison unavailable (C8)
Graham ?
€51.2
Pahalı
Active Metric?
3/4
Confidence?
64%
Valuation
Potential?
-34.1%
ROIC ?
4.1%
DCF Value ?
45.61
Debt Cycle?
Geç Genişleme
Data
Data ?
4711
2007-11-02 → 2026-08-31
Risk Analysis (VaR)
Çok Yüksek
252 days
Annual Volatility ?
%83.0
VaR 95% ?
%7.65
daily max loss
VaR 99% ?
%11.21
daily max loss
CVaR 95% ?
%8.85
expected loss (tail)
Max Drawdown ?
%50.1
22.06.2026 → 29.07.2026
Skewness ?
1.32
Parametrik%7.65
Historik%6.61
Cornish-Fisher%4.71
Return Distribution
Fundamental & Technical Analysis
TRAMA-99 Trend — Near TRAMA
Price (153.20), TRAMA-99 line (151.24) at close levels (%+1.3). Important decision zone — breakout direction will determine the trend.
Price:: 153.2
TRAMA: 151.2445
Difference: %+1.3
Profitability
Net Profit Margin
%2.9
Net profit margin %2.9 — positive but low. Compared to previous quarter -2.3 point decrease.
ROE – Özkaynak Getirisi (TTM)
%3.8
ROE %3.8 — low return on equity.
EBITDA Margin
%20.0
EBITDA margin %20.0 — good operational performance.
Gross Profit Margin
%12.1
Gross profit per revenue %12.1. Evaluate relative to sector.
Free Cash Flow Margin (TTM)
%6.2
TTM Free Cash Flow is %6.2'i. Moderate FCF — capex constraining operational profit.
Valuation
P/B Ratio
5.66x
Sector: 1.51x
PD/DD 5.66x — sector median's %275 above. Expensive book value.
EV/EBITDA
10.7x
Sector: 8.4x
EV/EBITDA 10.7x — sector median's (8.4x) %26 above. EBITDA’ya göre pahalı.
Indebtedness
Current Ratio
1.30x
Current ratio 1.30x — can comfortably cover short-term debts.
Net Debt / EBITDA
3.0x
Net Borç/EBITDA 3.0x — high debt burden. Borç servisi baskı oluşturuyor.
Debt / Equity
1.94x
Borç/Özkaynak 1.94x — high leverage. Sensitive to debt cycle changes.
Interest Coverage
10.1x
Interest coverage 10.1x — very wide margin for paying interest expenses.
Growth
Revenue Growth (YoY)
%+21.3
Revenue YoY %21.3 grew — healthy growth rate.
Net Profit Growth (YoY)
%-92.6
Net profit YoY %-92.6 declined (2026/3) — serious profit erosion.
Score Explanations
Lothien Robustness
31/100
Weak robustness (31/100). Valuation metrics and/or debt profile are unfavorable; caution is needed.
Weak
Potential
-34.1%
Minus %34.1 expected value (100.91) vs current price comparison. 3/4 valuation models give 'BUY' signal. Model confidence %64.
Components: P/B target: 42.36 | EV/EBITDA target: 121.36 | DCF target: 45.61
Damodaran Valuation
19/100
Low Damodaran score (19/100). ROIC (%4.1) below cost of capital. DCF analysis does not support current price.
Very Weak
Dalio Risk Analysis
53/100
Moderate debt risk (53/100). Interest coverage ratio 10.1x — strong. Borç/EBITDA 3.0x — manageable.
Leverage: 57/100 | Debt Service: 82/100 | Quality: 43/100
ROIC – Sermaye Getirisi
%4.1
ROIC (%4.1) cost of capitaln (7.8%) below → destroying value.
WACC: %7.8
DCF Discounted Cash Flow
45.61
DCF (45.61) current price %70.2 below — cash flows do not support current price.
Current price: 153.20
Debt Cycle Phase
Geç Genişleme
Debt cycle phase: Geç Genişleme
Piotroski F-Score
5/9
Moderate Piotroski (5/9). Some balance sheet criteria met, some missing. Note: Previous period ROA data missing (C1 delta-ROA); Önceki yıl borç/varlık verisi yok → kaldıraç azalması kontrol edilemedi (C5)
Neutral
Graham Intrinsic Value
€51.2
Güncel fiyat Graham valuenin %66.6 üzerinde (€51.2) — Expensive by Graham.
Expensive
⚖️ Sector Comparison
P/B Ratio
5.66x
vs 1.51x
Compared to sector %275 more expensive (by book value)
EV/EBITDA
10.7x
vs 8.4x
Compared to sector %26 higher EV/EBITDA
ROIC vs WACC
%4.1
vs %7.8 WACC
ROIC 3.7 baz puan cost of capitaln altında
Net Profit Margin (TTM)
%9.6
vs %39.2 EBITDA margin
TTM net profit margin %9.6
Charts
Indicators
BB deviation
?
RSI thresholds
?
ATS — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.